The MVP-5 system is used to reduce or obstruct blood flow for vessels between 3 and 5 mm in the peripheral vasculature.
More Articles on FDA Approvals:
FDA Approves Second Drug in Two Weeks to Treat Hepatitis C
4 Latest FDA Approvals
FDA Approves Linzess for Irritable Bowel Syndrome and Constipation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
